ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2411

Multiple Genetic Susceptibility Loci in Juvenile Idiopathic Arthritis Are Bound By a Set of Transcription Factors

Leah C. Kottyan1, Halima Moncrieffe2, Xiaoting Chen3, Mario Pujato4, John B. Harley5, Matthew Weirauch6 and Susan D. Thompson7, 13333 Burnet Ave., Cincinnati, Cincinnati, OH, 2Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Cincinnati Childrens Hospital, Cincinnati, OH, 41Center of Autoimmune Genomics and Etiology (CAGE), Cincinnati Children’s Hospital Medical Center; University of Cincinnati, Cincinnati, OH, 5Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Childrens Hospital, Cincinnati, OH, 6Division of Biomedical Informatics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 7Center for Autoimmune Disease Genomics and Etiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: GWAS, NFB, T cells, Vitamin D and juvenile idiopathic arthritis-enthesitis (ERA)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Pediatric Rheumatology – Pathogenesis and Genetics - Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Genome wide association studies (GWASs) and dense genotyping of immune-related disease regions have identified 17 loci associated with juvenile idiopathic arthritis (JIA) (p<5×10-8), 11 further loci with suggestive evidence for association (p<1×10-6), and 2 additional independent loci remaining after stepwise regression in the STAT1/STAT4 region. Given that the majority of these genome-wide associations are located in non-coding regions of the genome, we investigated if specific TFs might bind DNA at multiple JIA-associated genetic loci.

Methods: We defined a locus as those variants that had disequilibrium at r2>0.8 with the most significant genotyped marker at the locus. We assembled a large collection of publically available datasets, including 1,613 chromatin immunoprecipitation with next generation sequencing (ChIP-Seq) datasets, and “Active Chromatin” maps generated from combinations of histone marks in 126 different cell and tissue types. We developed a simulation test to assess the statistical significance of the number of JIA loci that intersect with each ChIP-seq dataset. To generate a null distribution, 2,000 simulations were performed in which each JIA locus was randomly assigned to a genomic location, maintaining linkage disequilibrium and allele frequency structure, and the intersect with each dataset was calculated. Bonferroni corrected P-values (pc) were estimated for each ChIP-seq dataset evaluated. We confined our attention to TF data sets that bound DNA in ≥3 JIA genetic loci and that had pc<0.01. The Toppgene web portal was used to characterize functional annotations and protein interactions between TFs.

Results: Our procedure implicates several immune cell types in JIA pathogenesis, including multiple CD4+ cells (Th cells, Th17 cells, Tregs, and memory T cells), CD56+ NKT cells, and CD8+ T cells. 95 of the 1,613 ChIP-seq datasets had pc<0.01. The top result involves STAT4 binding in IL-12 stimulated CD4+ Th1 cells (pc<10-12, 24-fold enrichment). Two Vitamin D receptor (VDR) ChIP-seq datasets are also highly significant (both pc<10-9), together comprising 7 of the 30 JIA loci. The 95 significant datasets collectively constitute 47 TFs (also including IRF3, STAT1, and RELA), which are significantly enriched for involvement in pathways that involve cytokine binding and activity (pc<10-4).

Conclusion: These data are consistent with common transcriptional control mechanisms operating across multiple JIA risk loci in a shared intracellular environment. Notably, most GWAS loci have small odds ratios (usually <1.2). If there are coordinated mechanisms across loci that alter disease risk with larger effect sizes, then shared gene regulatory mechanisms such as these are important in generating disease risk.


Disclosure: L. C. Kottyan, None; H. Moncrieffe, None; X. Chen, None; M. Pujato, None; J. B. Harley, None; M. Weirauch, None; S. D. Thompson, None.

To cite this abstract in AMA style:

Kottyan LC, Moncrieffe H, Chen X, Pujato M, Harley JB, Weirauch M, Thompson SD. Multiple Genetic Susceptibility Loci in Juvenile Idiopathic Arthritis Are Bound By a Set of Transcription Factors [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/multiple-genetic-susceptibility-loci-in-juvenile-idiopathic-arthritis-are-bound-by-a-set-of-transcription-factors/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/multiple-genetic-susceptibility-loci-in-juvenile-idiopathic-arthritis-are-bound-by-a-set-of-transcription-factors/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology